End Cash: The amount of cash held by the company for the given period.
Hemab Therapeutics Holdings, Inc. (COAG) had End Cash of 49.86M for the most recently reported fiscal quarter, ending 2026-03-31.
| Income Statement Financials | |
-- |
|
-22.69M |
|
-- |
|
-- |
|
23.61M |
|
-23.61M |
|
0.94M |
|
-22.68M |
|
-22.68M |
|
-22.69M |
|
-22.69M |
|
-22.69M |
|
-22.69M |
|
-23.61M |
|
-23.54M |
|
0.95M |
|
0.95M |
|
-23.98 |
|
-23.98 |
|
| Balance Sheet Financials | |
169.43M |
|
0.65M |
|
5.83M |
|
175.26M |
|
13.19M |
|
-- |
|
360.69M |
|
373.88M |
|
-198.62M |
|
-198.62M |
|
-198.62M |
|
0.95M |
|
| Cash Flow Statement Financials | |
-21.58M |
|
-15.85M |
|
-0.46M |
|
87.97M |
|
|
End Cash |
49.86M |
-38.11M |
|
1.32M |
|
-- |
|
-- |
|
| Fundamental Metrics & Ratios | |
12.85 |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-21.70M |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
11.42% |
|
11.42% |
|
-12.94% |
|
11.42% |
|
-209.96 |
|
-22.93 |
|
-22.82 |
|